This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Jan;41(1):1-2.

doi: 10.3899/jrheum.131116.

A decade of data discloses the window is still not clear

Marc Cohen¹

Affiliations

PMID: 24382923
DOI: 10.3899/jrheum.131116

Editorial

A decade of data discloses the window is still not clear

Marc Cohen. J Rheumatol. 2014 Jan.

. 2014 Jan;41(1):1-2.

doi: 10.3899/jrheum.131116.

Author

Marc Cohen¹

Affiliation

¹ Division of Rheumatology, University of Colorado Medical Center, 668 Humboldt St., Denver, Colorado 80218, USA.

PMID: 24382923
DOI: 10.3899/jrheum.131116

No abstract available

PubMed Disclaimer

Comment on

Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension.
Keystone EC, Breedveld FC, van der Heijde D, Landewé R, Florentinus S, Arulmani U, Liu S, Kupper H, Kavanaugh A. Keystone EC, et al. J Rheumatol. 2014 Jan;41(1):5-14. doi: 10.3899/jrheum.130543. Epub 2013 Nov 15. J Rheumatol. 2014. PMID: 24241487 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information